Search results
With roots deeply planted in Canadian soil, and decades of experience navigating the complex Canadian healthcare system, we are your guide for strategic commercialization in Canada. We will help you seamlessly navigate entry to market, and improve patient outcomes. Learn how we can support you.
Jun 6, 2024 · Cencora, a wholesale drug company formerly known as AmerisourceBergen and the parent company of The Lash Group, announced in May 2024 that an unauthorized third party accessed its network and exfiltrated sensitive data.
May 27, 2024 · Around 20% of pharmaceutical products sold and distributed in the United States are handled by Cencora. Last week, clients of Cencora and The Lash Group started notifying state Attorneys General about the data breach.
Jan 24, 2023 · AmerisourceBergen intends to begin operating as Cencora in the second half of calendar year 2023. The change to Cencora is aligned with the organization’s growth strategy and continued emphasis on innovation.
Innomar Strategies, a part of Cencora, is Canada’s leading patient support provider for specialty pharmaceuticals. We deliver end-to-end support solutions to improve product...
Jun 14, 2024 · Innomar Strategies est une filiale du géant américain de la distribution de médicaments Cencora. Les données médicales et personnelles de patients d’Innomar Strategies – une importante...
Jun 14, 2024 · Medical and personal patient data from Innomar Strategies – a major Canadian pharmaceutical company – was stolen following an intrusion into the parent company’s computer system. Potential victims interviewed by La Presse did not know that this company had access to this sensitive information.
